Yes, but you should carry a copy of the prescription and the original packaging. Some countries may require proof of prescription for antihistamines, so keeping documentation helps avoid customs delays.
Doxylamine is not typically screened for in standard workplace or sports drug tests. However, athletes should check specific league policies, as some governing bodies list antihistamines as prohibited substances when taken in high doses.
Each 10 mg/10 mg tablet is usually imprinted with the letters “D 10/10” on one side, identifying the dose and brand. Imprint designs can vary by manufacturer and batch.
The medication should be stored below 30 °C. In hot climates, keep the bottle in a climate-controlled area, such as a locked drawer away from windows or a cooler bag, to maintain potency.
Vitamin B6 alone may reduce mild nausea, but the addition of doxylamine provides a sedative effect that improves overall symptom control. Clinical trials have shown the combination to be more effective than either component alone for NVP.
Yes, it can be prescribed throughout pregnancy if nausea persists, but clinicians often reassess the need in the third trimester and may adjust the dose or discontinue based on symptom severity and fetal considerations.
Small amounts of doxylamine and pyridoxine are excreted in breast milk. Most guidelines consider short-term use compatible with breastfeeding, but a prescriber should weigh maternal benefit against potential infant exposure.
Increase dietary fibre, hydrate well, and consider a mild stool softener after discussing it with your healthcare provider. Persistent constipation should be evaluated for other causes.
The excipients in Diclegis tablets typically include lactose, magnesium stearate, and other standard fillers. Patients with known lactose intolerance or gluten sensitivity should confirm ingredient details with the pharmacy.
Diclegis is a prescription medication that combines two active ingredients - doxylamine succinate and pyridoxine (vitamin B6) - in a single tablet. It belongs to the women’s health therapeutic area and is primarily used to relieve nausea and vomiting during pregnancy, a condition known as nausea and vomiting of pregnancy (NVP).
Diclegis treats NVP through the complementary actions of its two components:
Doxylamine succinate is a first-generation antihistamine. It blocks histamine H₁ receptors in the brain, producing a mild sedative effect that can reduce the sensation of nausea. Doxylamine also has anticholinergic activity, which can further diminish the vomiting reflex.
Pyridoxine (vitamin B6) participates in neurotransmitter synthesis, particularly the production of serotonin and dopamine, which influence the gut-brain axis. Adequate pyridoxine levels are thought to stabilise the central pathways that trigger nausea.
When taken together, the antihistamine’s calming effect and pyridoxine’s metabolic support provide greater relief than either agent alone. The tablet is designed for oral absorption; peak plasma concentrations are typically reached within 2-4 hours, and the combined effect can last through the night, which is why the medication is usually taken at bedtime.
Nausea and vomiting of pregnancy (NVP): Diclegis is approved by the US Food and Drug Administration (FDA) for the treatment of mild-to-moderate NVP. In the UK it is commonly prescribed off-label for the same indication when first-line dietary measures are insufficient.
Hyperemesis gravidarum (severe NVP): Although not formally approved for hyperemesis gravidarum, clinical guidelines recognise that higher-dose regimens of doxylamine-pyridoxine may be employed under specialist supervision when symptoms are severe.
The medication is not indicated for nausea unrelated to pregnancy, such as chemotherapy-induced nausea, postoperative nausea, or motion sickness, unless a prescriber specifically deems it appropriate.
Post-operative nausea: Small observational studies have explored doxylamine-pyridoxine for nausea after surgery, but evidence remains limited and the use is not standard practice.
Chemotherapy-induced nausea: Research to date does not support routine use of doxylamine-pyridoxine for this purpose; anti-emetics with stronger evidence, such as 5-HT₃ antagonists, are preferred.
When used off-label, the same safety considerations and dosing principles apply, and any such use must be supervised by a qualified healthcare professional.
Ideal candidates
Absolute contraindications
Relative contraindications / cautions
Special populations
These effects are usually transient and lessen as the body adjusts to the medication.
Diclegis does not carry a US “black-box” warning, but the MHRA advises caution in patients with the relative contraindications listed above.
When any new medication, herbal product, or supplement is added, the prescriber should review the full list for potential interactions.
This article provides educational information about Diclegis and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
